Back
Nurix Therapeutics, Inc. 10K Form
Buy
100
NRIX
Nurix Therapeutics, Inc.
Last Price:
$20.92
Seasonality Move:
-4.23%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive NRIX News And Ratings
See the #1 stock for the next 7 days that we like better than NRIX
NRIX Financial Statistics
Sales & Book Value
| Annual Sales: | $54.5M |
|---|---|
| Cash Flow: | $-60.1M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $4.84 |
| Price / Book: | 4.43 |
Profitability
| EPS (TTM): | -2.96620 |
|---|---|
| Net Income (TTM): | $-244.8M |
| Gross Margin: | $38.1M |
| Return on Equity: | -55.52% |
| Return on Assets: | -41.94% |
Nurix Therapeutics, Inc. Earnings Forecast
Key Nurix Therapeutics, Inc. Financial Ratios
-
The Gross Profit Margin over the past 7 years for NRIX is 69.88%.
-
The Selling, General & Administrative Expenses for NRIX have been equal to 84.23% of Gross Profit Margin.
-
The Research & Development expenses have been 389.22% of Revenue.
-
The Net Earning history of NRIX is -354.85% of Total Revenues.
-
Per Share Earnings over the last 7 years have been positive in 2 years.
Nurix Therapeutics, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | NRIX |
| CUSIP: | 67080M |
| Website: | nurixtx.com |
Debt
| Debt-to-Equity Ratio: | 0.15 |
|---|---|
| Current Ratio: | 5.35 |
| Quick Ratio: | 5.21 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
NRIX Technical Analysis vs Fundamental Analysis
Buy
100
Nurix Therapeutics, Inc. (NRIX)
is a Buy
Is Nurix Therapeutics, Inc. a Buy or a Sell?
-
Nurix Therapeutics, Inc. stock is rated a BuyThe current Nurix Therapeutics, Inc. [NRIX] share price is $21.47. The Score for NRIX is 100, which is 100% above its historic median score of 50, and infers lower risk than normal.